2020 ASCO Virtual Direct™ Highlights
Playback speed
10 seconds
2020 ASCO Update on AML: Are Ivosidenib and Enasidenib Good Options to Be Added to the Backbone of HMAs?
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Vij
By
2020 ASCO Virtual Direct™ Highlights
FEATURING
Ravi Vij
115 views
July 22, 2020
Login to view comments.
Click here to Login
Hematologic Oncology